Clinical trial Recruiting at 3 sites Interventional Ages 22 and up

Epione-assisted introducer placement for percutaneous pelvic and spine procedures

Official title: Evaluation of the Epione Robotic System for Image-guided Percutaneous MSK Procedures of the Pelvis and Spine in USA. A Prospective Study on Feasibility, Safety and Accuracy

Run by Precision IO Group · NCT07325578 · Data updated 2026-11-12

This will test whether the Epione device can help doctors place introducers during CT- or CBCT-guided percutaneous pelvic or spine procedures in adults.

More Osteoporosis trials

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment60 (estimated)
SponsorPrecision IO Group
Industry-sponsored
Locations3 sites (San Diego, California and 2 other locations)
StatusRecruiting
StartedApril 28, 2026
Main results expectedJanuary 2027
Study endsMarch 2027
Registry record updatedJuly 20, 2026
Trial IDNCT07325578 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 22 or older who are approved for CT- or CBCT-guided percutaneous procedures in the pelvis or thoraco-lumbar spine under general anesthesia, can give informed consent, and have routine-cost coverage are ideal candidates.

Probably not a fit

Patients needing procedures outside the specified target areas (including the cervical spine), those who cannot undergo general anesthesia or extra CT/CBCT imaging, pregnant or breastfeeding individuals, or those unable to consent are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This investigational device exemption tests the Epione robotic assistance for introducer placement during CT- or CBCT-guided percutaneous musculoskeletal procedures of the pelvis and thoraco-lumbar spine in adults. Participants will undergo their planned procedure under general anesthesia, with the Epione device used to guide introducer placement instead of freehand technique and with additional intra-procedural CT or CBCT imaging. The primary outcome is the rate of feasible procedures achieved with Epione-assisted introducer placement. The study enrolls adults aged 22 and older at three U.S. centers and follows routine coverage for standard-of-care costs.

Why it matters

Potential benefit: If successful, Epione could make introducer placement more consistent and accurate, potentially reducing procedure time and procedural complications.

How similar studies have gone: Previous work with robot-assisted or image-guided systems has shown improved needle or instrument placement accuracy for spine and pelvic procedures, but the Epione device itself is newly investigational in the U.S.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients ≥22 years old,
* Patients approved for CT- or CBCT-guided MSK procedure in the pelvis or spine (except the cervical area) under general anesthesia,
* Patients who have signed an IRB-approved informed consent form
* Patients approved for coverage by their insurance for routine costs involved in this standard of care procedure
* Inclusion criteria linked to the freehand procedure have been discussed and validated

Exclusion Criteria:

* Patients with contraindication to undergo general anesthesia,
* Patients unable to maintain appropriate breathing control,
* Patients requiring CT- or CBCT-guided percutaneous procedure on target areas other than those indicated
* Patients unable to fully understand all relevant aspects of the clinical study necessary for their decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response,
* Pregnant or breast-feeding women,
* Patients subject to a legal protection measure,
* Patients already participating in another conflicting interventional clinical study,
* Patients for whom the scan field of view cannot contain the anatomy of interest, the overlaying skin surface, skin markers and the whole patient reference.
* Patients having a coagulation abnormalities or bleeding disorder
* Patients having an active infection on the day of intervention
* Patients having a history of previous surgery resulting in an existing hardware precluding percutaneous approach
* Exclusion criteria linked to the freehand procedure have been discussed and validated

Where it's running

  • UC San Diego
    San Diego, California, United States
    Recruiting
  • Baptist Hospital Of Miami, Inc
    Miami, Florida, United States
    Recruiting
  • Rush University Medical Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.